Steroid use in elderly critically ill COVID-19 patients

This secondary analysis of the COVIP study shows a higher 30-day mortality in critically ill elderly COVID-19 patients who received steroids as part of their treatment @cjungMD https://bit.ly/3xdyEur

Detalles Bibliográficos
Autores principales: Jung, Christian, Wernly, Bernhard, Fjølner, Jesper, Bruno, Raphael Romano, Dudzinski, David, Artigas, Antonio, Bollen Pinto, Bernardo, Schefold, Joerg C., Wolff, Georg, Kelm, Malte, Beil, Michael, Sigal, Sviri, van Heerden, Peter Vernon, Szczeklik, Wojciech, Czuczwar, Miroslaw, Elhadi, Muhammed, Joannidis, Michael, Oeyen, Sandra, Zafeiridis, Tilemachos, Marsh, Brian, Andersen, Finn H., Moreno, Rui, Cecconi, Maurizio, Leaver, Susannah, Boumendil, Ariane, De Lange, Dylan W., Guidet, Bertrand, Flaatten, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246007/
https://www.ncbi.nlm.nih.gov/pubmed/34172464
http://dx.doi.org/10.1183/13993003.00979-2021
Descripción
Sumario:This secondary analysis of the COVIP study shows a higher 30-day mortality in critically ill elderly COVID-19 patients who received steroids as part of their treatment @cjungMD https://bit.ly/3xdyEur

Ejemplares similares